Depression

A new study links direct-to-consumer (DTC) advertising to increased testosterone treatment, even when patients do not have a diagnosable condition.

Ultimately, the FDA Advisory Committee recommended approval of brexanolone by a 17-1 member vote. I was the only NO vote. I voted NO because as the sole Consumer Representative on the committee I didn’t believe the company had demonstrated that the potential benefits outweighed the potential for harm.

The University of Manchester in England, along with the D'Or Insitute in Rio de Janeiro, Brazil, have found that differences in activity in the...

Antidepressants can affect neurotransmitters involved in regulation of the iris, say researchers in the Journal of Clinical Psychopharmacology. In a study of  acute angle-closure...

Therapists can use music to meet the emotional and social needs of individuals with dementia.

A prospective cohort study of those labeled high risk for psychosis finds a higher prevalence of antidepressant use among those who develop manic symptoms.

Allen Frances, writing in the Huffington Post, calls the decision in the forthcoming DSM-5 to call grief in the bereaved a disorder as soon as...

In this video for AdvancingMentalHealth.org, Jeff Baker provides a detailed overview and critique of the chemical imbalance theory of mental illness.

A new BBC documentary, "Health," investigates the deals struck between health professionals and pharmaceutical companies. The documentary includes an interview with Dr. James Davies, co-founder of the...

Article Abstract: Although research supports the stigma and labeling perspective, empirical evidence also indicates that a social safety net remains intact for those with mental...

Researchers at Tufts University exposed rats and their children to early life stress, resulting in depressed maternal care, aggression, increased restlessness and anxiety-related...

A Molecular Psychiatry study found that people who had recurrent depression developed smaller hippocampi and antidepressants protected against that effect -- except insofar as the study evidence seemed to show the opposite of what the media reported on it.

A new study tracks the approval of the latest antidepressant, vortioxetine, by the Federal Drug Administration (FDA) and the European Medicines Agency (EMA). The...

From Elite Daily: Courtney Lorking, an 18-year-old online wellness coach and fitness enthusiast, is speaking out and sharing her story of how exercise helped her...

The New York Post reprints an excerpt on antidepressants from the latest book by MIA contributor, Kelly Brogan, MD, “A Mind of Your Own:...

In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.

An investigative report in the Milwaukee-Wisconsin Journal Sentinel explores the pharmaceutical industries involvement in the creation of the ‘mental illness’ known as Premenstrual Dysphoric Disorder...

Professionals are paid to share their wisdom with those who are, typically, less informed. But, when dealing with mental health professionals in the psychiatric arena, it is wise to retain a degree of skepticism about the words spoken by the doctors and nurses commissioned to help reduce human misery and suffering.

The U.K.'s Guardian writes today that "the proposal by the American Psychiatric Association to create a new illness – prolonged grief disorder – and...

In a study published yesterday, researchers from the Nippon Medical School in Tokyo bring attention to a condition known as neuroleptic-induced deficit syndrome (NIDS)...

Researchers distinguish between two different forms of perspective taking and examine their impact on helpers’ wellbeing.

From The New York Times: According to Dr. Andrew Weil, who is best known for popularizing the concept of integrative medicine, the problem of overmedication...

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

There is robust evidence for the long-term effectiveness of psychotherapy, and it also provides good value-for-money, according to a large randomized control trial published open-access this month in The Lancet. The researchers recommend that clinicians refer all patients with treatment-resistant depression to therapy.